Literature DB >> 30168133

Preparation, characterization and antimicrobial activity of inclusion complex of biochanin A with (2-hydroxypropyl)-β-cyclodextrin.

Ivana Lj Nikolic1, Ivan M Savic1, Mirjana M Popsavin2, Srdjan J Rakic3, Tatjana M Mihajilov-Krstev4, Ivan S Ristic5, Suzana P Eric6, Ivana M Savić-Gajic1.   

Abstract

OBJECTIVES: An inclusion complex of biochanin A (BCA) with (2-hydroxypropyl)-β-cyclodextrin (HP-β-CD) was prepared in the ethanol solution to improve its water solubility.
METHODS: Using the FTIR, 1 H-NMR, XRD, DSC and SEM methods, the structural characterization of the prepared complex was analysed. KEY
FINDINGS: The phase-solubility study has shown that the solubility of BCA was increased twofold in 42% (v/v) ethanol solution after complexation with HP-β-CD. The complex between BCA and HP-β-CD was prepared in the molar ratio of 1 : 1. The antibacterial activity of the inclusion complex was investigated against the various bacteria, fungus and yeast using the microdilution method. The minimal inhibitory concentration values for the analysed strain of bacteria were in the range of 0.84-1.69 mg/cm3 , whereby the prepared inclusion complex exhibited less effect on the reduction of the number of Escherichia coli and Klebsiella pneumoniae species compared to pure BCA. The inclusion complex of BCA was significantly more active against Candida albicans than pure BCA. Biochanin A and its inclusion complex has not expressed the activity against Aspergillus niger.
CONCLUSIONS: Based on the obtained results, it can be concluded that the antimicrobial activity of BCA was remained unchanged after complexation.
© 2018 Royal Pharmaceutical Society.

Entities:  

Keywords:  characterization; inclusion complex; isoflavone; solubility enhancement

Mesh:

Substances:

Year:  2018        PMID: 30168133     DOI: 10.1111/jphp.13003

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  8 in total

1.  Escaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds.

Authors:  Ragi Jadimurthy; Shilpa Borehalli Mayegowda; S Chandra Nayak; Chakrabhavi Dhananjaya Mohan; Kanchugarakoppal S Rangappa
Journal:  Biotechnol Rep (Amst)       Date:  2022-04-04

2.  Preparation and Properties of Cyclodextrin Inclusion Complexes of Hyperoside.

Authors:  Xinyu Zhang; Jianqing Su; Xiaoya Wang; Xueyan Wang; Ruixue Liu; Xiang Fu; Ying Li; Jiaojiao Xue; Xiaoli Li; Rui Zhang; Xiuling Chu
Journal:  Molecules       Date:  2022-04-25       Impact factor: 4.927

Review 3.  Cyclodextrin⁻Drug Inclusion Complexes: In Vivo and In Vitro Approaches.

Authors:  Simone Braga Carneiro; Fernanda Ílary Costa Duarte; Luana Heimfarth; Jullyana de Souza Siqueira Quintans; Lucindo José Quintans-Júnior; Valdir Florêncio da Veiga Júnior; Ádley Antonini Neves de Lima
Journal:  Int J Mol Sci       Date:  2019-02-02       Impact factor: 5.923

4.  Preparation, Characterization, and Bioavailability of Host-Guest Inclusion Complex of Ginsenoside Re with Gamma-Cyclodextrin.

Authors:  Hui Li; Guolei Zhang; Wei Wang; Changbao Chen; Lili Jiao; Wei Wu
Journal:  Molecules       Date:  2021-11-29       Impact factor: 4.411

5.  Antibiotic Isoflavonoids, Anthraquinones, and Pterocarpanoids from Pigeon Pea (Cajanus cajan L.) Seeds against Multidrug-Resistant Staphylococcus aureus.

Authors:  Lex Aliko P Balida; Julia Theresa A Regalado; Jade Joshua R Teodosio; Kathryn Ann H Dizon; Zhe Sun; Zhao Qi Zhan; Jenny Marie D Blancaflor; Jan Vincent N Sollesta; Zenith M Villorente; Jonel P Saludes; Doralyn S Dalisay
Journal:  Metabolites       Date:  2022-03-23

6.  Enhanced Antioxidant, Antiviral, and Anticancer Activities of the Extract of Fermented Egyptian Rice Bran Complexed with Hydroxypropyl-β-cyclodextrin.

Authors:  Sherif Ashraf Fahmy; Khaled A Nematallah; Noha Khalil Mahdy; Hesham I El-Askary; Meselhy Ragab Meselhy; Hassan Mohamed El-Said Azzazy
Journal:  ACS Omega       Date:  2022-06-01

Review 7.  Nanostructured Antibiotics and Their Emerging Medicinal Applications: An Overview of Nanoantibiotics.

Authors:  Shreya Modi; Gajendra Kumar Inwati; Amel Gacem; Shahabe Saquib Abullais; Rajendra Prajapati; Virendra Kumar Yadav; Rabbani Syed; Mohammed S Alqahtani; Krishna Kumar Yadav; Saiful Islam; Yongtae Ahn; Byong-Hun Jeon
Journal:  Antibiotics (Basel)       Date:  2022-05-25

8.  Electrospun Poly(lactide) Fibers as Carriers for Controlled Release of Biochanin A.

Authors:  Ivana Gajić; Sanja Stojanović; Ivan Ristić; Snežana Ilić-Stojanović; Branka Pilić; Aleksandra Nešić; Stevo Najman; Ana Dinić; Ljiljana Stanojević; Maja Urošević; Vesna Nikolić; Ljubiša Nikolić
Journal:  Pharmaceutics       Date:  2022-02-27       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.